Forward PE Ratio: 14.93

Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.

The forward PE ratio is 14.93.

Forward PE Ratio (14.93) = Close Price ($807.65) / Consensus Forward EPS ($54.26)

REGN Forward PE Ratio Metrics

Trailing vs Forward

The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $54.26 implies +34.2% EPS growth vs the reported trailing $40.43.

At today's $807.65 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.

Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.

Forward PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Forward PE Ratio FAQ

What is the forward PE ratio for Regeneron Pharmaceuticals, Inc. (REGN)?

The forward PE ratio for REGN stock is 14.93.

Related Metrics